Similarly, CD38 has been identified as an independent prognostic factor in patients with triple-negative breast cancer, where higher expression of CD38 on tumor-infiltrating plasma cells is associated with increased metastasis-free survival and overall survival [51]. The gene discussed is CD38; the disease is triple-negative breast carcinoma.